This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2005 Oct;90(10):1300A.

Bendamustine in relapsed or refractory chronic lymphocytic leukemia

Alessandra Ferrajoli¹

Affiliations

PMID: 16219556

Comment

Bendamustine in relapsed or refractory chronic lymphocytic leukemia

Alessandra Ferrajoli. Haematologica. 2005 Oct.

. 2005 Oct;90(10):1300A.

Author

Alessandra Ferrajoli¹

Affiliation

¹ Department of Leukaemia, The University of Texas, MD Anderson Cancer Center, Houston, USA. aferrajo@mdanderson.org

PMID: 16219556

No abstract available

PubMed Disclaimer

Comment on

Efficacy of bendamustine in patients with relapsed or refractory chronic lymphocytic leukemia: results of a phase I/II study of the German CLL Study Group.
Bergmann MA, Goebeler ME, Herold M, Emmerich B, Wilhelm M, Ruelfs C, Boening L, Hallek MJ; German CLL Study Group. Bergmann MA, et al. Haematologica. 2005 Oct;90(10):1357-64. Haematologica. 2005. PMID: 16219572 Clinical Trial.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Other Literature Sources
- The Lens - Patent Citations Database